期刊
PHARMACOGENOMICS
卷 19, 期 7, 页码 667-685出版社
FUTURE MEDICINE LTD
DOI: 10.2217/pgs-2017-0207
关键词
genotype-guided dosing algorithms; pharmacogenetic-based algorithm; pharmacogenetics; polymorphisms; vitamin k antagonist; warfarin
资金
- Sao Paulo Research Foundation (FAPESP) [2013/09295-3, 2016/22507-8, 2016/23454-5]
Warfarin pharmacogenomics has been an extensively studied field in the last decades as it is focused on personalized therapy to overcome the wide interpatient warfarin response variability and decrease the risk of side effects. In this expert review, besides briefly summarizing the current knowledge about warfarin pharmacogenetics, we also present an overview of recent studies that aimed to assess the efficacy, safety and economic issues related to genotype-based dosing algorithms used to guide warfarin therapy, including randomized and controlled clinical trials, meta-analyses and cost-effectiveness studies. To date, the findings still present disparities, mostly because of standard limitations. Thus, further studies should be encouraged to try to demonstrate the benefits of the application of warfarin pharmacogenomic dosing algorithms in clinical practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据